Literature DB >> 32275078

Relationship between Sphk1/S1P and microRNAs in human cancers.

Saeideh Gholamzadeh Khoei1,2, Hamid Sadeghi3, Pouria Samadi1,2, Rezvan Najafi1, Massoud Saidijam1.   

Abstract

Sphingosine kinases type 1 (SphK1) is a key enzyme in the phosphorylation of sphingosine to sphingosine 1-phosphate (S1P). Different abnormalities in SphK1 functions may correspond with poor prognosis in various cancers. Additionally, upregulated SphK1/S1P could promote cancer cell proliferation, angiogenesis, mobility, invasion, and metastasis. MicroRNAs as conserved small noncoding RNAs play major roles in cancer initiation, progression, metastasis, etc. Their posttranscriptionally mechanisms could affect the development of cancer growth or tumorigenesis suppression. The growing number of studies has described that various microRNAs can be regulated by SphK1, and its expression level can also be regulated by microRNAs. In this review, the relationship of SphK1 and microRNA functions and their interaction in human malignancies have been discussed. Based on them novel treatment strategies can be introduced.
© 2020 International Union of Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  cancer; interaction; microRNAs; sphingosine 1-phosphate; sphingosine kinase type 1

Year:  2020        PMID: 32275078     DOI: 10.1002/bab.1922

Source DB:  PubMed          Journal:  Biotechnol Appl Biochem        ISSN: 0885-4513            Impact factor:   2.431


  2 in total

Review 1.  Targeting Sphingosine-1-Phosphate Signaling in Immune-Mediated Diseases: Beyond Multiple Sclerosis.

Authors:  Tamara Pérez-Jeldres; Manuel Alvarez-Lobos; Jesús Rivera-Nieves
Journal:  Drugs       Date:  2021-05-13       Impact factor: 11.431

2.  Long non-coding RNA 00960 promoted the aggressiveness of lung adenocarcinoma via the miR-124a/SphK1 axis.

Authors:  Zhipeng Ge; Haibo Liu; Tao Ji; Qiaoling Liu; Lulu Zhang; Pengchong Zhu; Liang Li; Liangming Zhu
Journal:  Bioengineered       Date:  2022-01       Impact factor: 3.269

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.